Home Cart Sign in  
Chemical Structure| 654671-77-9 Chemical Structure| 654671-77-9

Structure of 654671-77-9

Chemical Structure| 654671-77-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Sitagliptin Phosphate Monohydrate is a potent inhibitor of DPP4 with IC50 of 19 nM in Caco-2 cell extracts.

Synonyms: MK-0431; MK-0431 phosphate monohydrate

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Mani, Vasudevan ; Arfeen, Minhajul ;

Abstract: Background/Objectives: Diabetes mellitus (DM), a widespread endocrine disorder charac_x005f_x0002_terized by chronic hyperglycemia, can cause nerve damage and increase the risk of neurodegenerative diseases such as Alzheimer’s disease (AD). Effective blood glucose management is essential, and sitagliptin (SITG), a dipeptidyl peptidase-4 (DPP-4) inhibitor, may offer neuroprotective benefits in type 2 diabetes mellitus (T2DM). Methods: T2DM was induced in rats using nicotinamide (NICO) and streptozotocin (STZ), and biomarkers of AD and DM-linked enzymes, inflammation, oxidative stress, and apoptosis were evaluated in the brain. Computational studies supported the in vivo findings. Results: SITG significantly reduced the brain enzyme levels of acetylcholinesterase (AChE), beta-secretase-1 (BACE-1), DPP-4, and glycogen synthase kinase-3β (GSK-3β) in T2DM-induced rats. It also reduced inflammation by lowering cyclooxygenase-2 (COX-2), prostaglandin E2 (PGE2), tumor necrosis factor-α (TNF-α), and nuclear factor-κB (NF-κB). Additionally, SITG improved oxidative stress markers by reducing malondialdehyde (MDA) and enhancing glutathione (GSH). It increased anti-apoptotic B-cell lymphoma protein-2 (Bcl-2) while reducing pro-apoptotic markers such as Bcl-2-associated X (BAX) and Caspace-3. SITG also lowered blood glucose levels and improved plasma insulin levels. To explore potential molecular level mechanisms, docking was performed on AChE, COX-2, GSK-3β, BACE-1, and Caspace-3. The potential binding affinity of SITG for the above-mentioned target enzymes were 10.8, 8.0, 9.7, 7.7, and 7.9 kcal/mol, respectively, comparable to co-crystallized ligands. Further binding mode analysis of the lowest energy conformation revealed interactions with the critical residues. Conclusions: These findings highlight SITG’s neuroprotective molecular targets in T2DM-associated neurodegeneration and its potential as a therapeutic approach for AD, warranting further clinical investigations.

Keywords: sitagliptin ; type 2 diabetes mellitus ; Alzheimer’s disease ; brain enzymes ; inflammation ; oxidative stress ; apoptosis ; molecular docking

Purchased from AmBeed: ; ;

Alternative Products

Product Details of Sitagliptin phosphate monohydrate

CAS No. :654671-77-9
Formula : C16H20F6N5O6P
M.W : 523.32
SMILES Code : O=C(N1CC2=NN=C(C(F)(F)F)N2CC1)C[C@H](N)CC3=CC(F)=C(F)C=C3F.O=P(O)(O)O.[H]O[H]
Synonyms :
MK-0431; MK-0431 phosphate monohydrate
MDL No. :MFCD19684081
InChI Key :GQPYTJVDPQTBQC-KLQYNRQASA-N
Pubchem ID :11591741

Safety of Sitagliptin phosphate monohydrate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P280-P305+P351+P338-P310

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Human skin fibroblasts 10 µM 24 hours Inhibited TGFβ1-induced alpha-smooth muscle actin (αSMA) production, reducing myofibroblast differentiation PMC8556235

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Diet-induced obese (DIO) mice Oral 30–45 mg/kg/day Once daily for 4 weeks To compare the effects of oral DPP4 inhibition with sitagliptin versus hepatocyte DPP4 silencing on adipose inflammation and glucose metabolism. Results showed that oral sitagliptin did not reduce adipose inflammation but improved glycemic control. PMC6021131
Mouse Full-thickness skin wound model Topical application 1 mM Daily for the first 7 days, then thrice a week for 7 weeks Demonstrated anti-fibrotic activity and improved scar quality PMC8556235
Mice Wild-type and GLP-1 receptor knockout mice Intraperitoneal injection 10 mg/kg Single administration Sitagliptin phosphate decreased nicotine self-administration in mice. PMC5541856
Mice Mice fed a high fat, fructose and cholesterol diet (HFFC) or control diet (CD) Dietary supplementation MK-0626 (15.5 mg per 4056 kcal of diet) 14 weeks To examine the effects of DPP4 inhibition on inflammation, it was found that DPP4 inhibition increased plasma levels of inflammatory markers in CD-fed mice but did not further increase them in HFFC-fed mice. PMC7387453

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00541229 Type 2 Diabetes Phase 1 Completed - -
NCT00961363 Impaired Glucose Tolerance Phase 2 Unknown - Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Lee-Ming Chuang, MD, PhD    886-2-23123456 ext 65038    leeming@ntu.edu.tw    Principal Investigator: Lee-Ming Chuang, MD, PhD          Sub-Investigator: Hung-Yuan Li, MD          Sub-Investigator: Hung-Ju Lin, MD          Sub-Investigator: Chia-Hsiung Chang, MD, PhD          Sub-Investigator: Shyang-Rong Shih, MD          Sub-Investigator: Tien-Jyun Chang, MD, PhD          Sub-Investigator: Jaw-Shiun Tsai, MD Less <<
NCT00541229 - Completed - -
NCT01590797 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01590797 - Completed - -
NCT00411554 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 3 Completed - -
NCT00411554 - Completed - -
NCT03115112 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01337440 Type 2 Diabetes Mellitus ... More >> Chronic Liver Disease Less << Phase 4 Unknown March 2013 Japan ... More >> Internal medicine, Kanazawa university hospital Recruiting Kanazawa, Ishikawa, Japan, 920-8641 Contact: Toshinari Takamura, MD, PhD    +81-76-265-2233    ttakamura@m-kanazawa.jp    Sub-Investigator: Kosuke R Shima, MD Less <<
NCT03125694 Uncontrolled Type 2 Diabetes M... More >>ellitus Less << Phase 3 Completed - Iran, Islamic Republic of ... More >> Tehran University of Medical Sciences Tehran, Iran, Islamic Republic of Less <<
NCT01378117 Type 2 Diabetes Mellitus ... More >> Hospitalization Hyperglycemia Less << Phase 4 Completed - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Emory University Hospital Atlanta, Georgia, United States, 30324 Less <<
NCT01485614 Diabetes Mellitus ... More >> Type 2 Diabetes Less << Phase 3 Active, not recruiting October 17, 2019 -
NCT01354990 - Completed - -
NCT01703637 Type 2 Diabetes Mellitus Not Applicable Unknown - China, Shandong ... More >> YuCheng people's hospital Recruiting Dezhou, Shandong, China, 253000 Contact: Pengfei Li       lpf9669@163.com    Hospital of SINOTRUK Recruiting Jinan, Shandong, China, 250010 Contact: Xiling Fu       fxl1936@163.com    Jinan central hospital Recruiting Jinan, Shandong, China, 250010 Contact: Shuguang Pang       shuguangpang@163.com    The jinan military region general hospital Recruiting Jinan, Shandong, China, 250010 Contact: Zhaoshun Jiang       zhaoshunjiang@sohu.com    Qianfoshan Hospital Recruiting Jinan, Shandong, China, 250012 Contact: Lin Liao, MD    8615168888260    liaolin@medmail.com.cn    People's Hospital of Qingdao Chengyang Recruiting Qingdao, Shandong, China, 266100 Contact: Xiaopang Rao       123raoxiaopang@163.com    Zibo central hospital Recruiting Zibo, Shandong, China, 255000 Contact: Xiaodong Zhao       19xiaodong@163.com    Zibo eighth people's hospital Recruiting Zibo, Shandong, China, 255000 Contact: Ling Dai    +86 13853388549 Less <<
NCT01354990 - Completed - -
NCT01378117 - Completed - -
NCT00758069 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 2 Completed - -
NCT01557504 - Completed - -
NCT01374568 Type 2 Diabetes Mellitus Phase 4 Terminated(Study closed by spo... More >>nsor. Funding ended.) Less << - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 Less <<
NCT00758069 - Completed - -
NCT01557504 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT01100125 Diabetes Phase 4 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Gyeonggi, Korea, Republic of, 463-707 Seoul National University Bundang Hospital Seongnam, Korea, Republic of Less <<
NCT00541450 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01374568 - Terminated(Study closed by spo... More >>nsor. Funding ended.) Less << - -
NCT00541450 - Completed - -
NCT00501657 Gastroparesis ... More >> Diabetes Mellitus Less << Phase 1 Completed - Australia, South Australia ... More >> Discipline of Medicine, Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 Less <<
NCT01545388 - Completed - -
NCT01545388 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02577003 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02577003 - Completed - -
NCT00420511 Type 2 Diabetes Mellitus Phase 2 Completed - Canada, Ontario ... More >> Leadership Sinai Centre for Diabetes Toronto, Ontario, Canada, M5T 3L9 Less <<
NCT01928199 Posttransplant Diabetes Mellit... More >>us Less << Phase 2 Recruiting December 2019 United States, Missouri ... More >> Washington University Recruiting Saint Louis, Missouri, United States, 63110 Contact: Rowena Delos Santos, MD    314-362-4547    delossantos@wustl.edu    Principal Investigator: Rowena Delos Santos, MD          Sub-Investigator: Daniel Brennan, MD          Sub-Investigator: Rebecca Cusanelli, RN, MSN          Sub-Investigator: Timothy Horwedel, PharmD          Sub-Investigator: Jennifer Hagopian, PharmD Less <<
NCT00420511 - Completed - -
NCT00820573 Diabetes Phase 4 Completed - United States, Texas ... More >> Texas Diabetes Institute San Antonio, Texas, United States, 78207 Less <<
NCT02650427 Hepato Carcinoma Phase 1 Completed - France ... More >> Pitié-Salpêtrière Hospital Paris, France, 75013 Less <<
NCT00820573 - Completed - -
NCT00960453 Diabetes Mellitus Phase 1 Completed - Korea, Republic of ... More >> Clinical Trials Center; Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT02576288 Atherosclerosis ... More >> Inflammation Less << Phase 2 Recruiting December 2017 United States, California ... More >> University of Southern California Health Sciences Campus Recruiting Los Angeles, California, United States, 90033 Contact: Evelyn Gonzalez    323-409-8286    evelyngo@usc.edu    Contact: Christina Dieli-Conwright, PhD    323-442-2905    cdieli@usc.edu Less <<
NCT02791490 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT03122041 PCOS Phase 4 Completed - -
NCT01092663 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94110 United States, Florida Clinical Pharmacology of Miami Miami, Florida, United States, 33014 United States, Texas Healthcare Discoveries, LLC d/b/a ICON Development Solutions San Antonio, Texas, United States, 78209 Less <<
NCT01703221 - Completed - -
NCT01092663 - Completed - -
NCT00337610 Type 2 Diabetes Mellitus (T2DM... More >>) Less << Phase 3 Completed - -
NCT01703221 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01155284 Type 1 Diabetes Phase 2 Completed - United States, California ... More >> Rady Children's Hospital San Diego, California, United States, 92123-4282 United States, Minnesota Children's - St. Paul Saint Paul, Minnesota, United States, 55102 United States, South Dakota Sanford Research/USD Sioux Falls, South Dakota, United States, 57104 Less <<
NCT01155284 - Completed - -
NCT00337610 - Completed - -
NCT01552694 Inflammation ... More >>Macrophage Infiltration Cardiovascular Disease Less << Phase 3 Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT02675335 Diabetic Foot Phase 3 Withdrawn March 2018 -
NCT01702298 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01552694 - Completed - -
NCT01702298 - Completed - -
NCT00451113 Type 2 Diabetes Phase 2 Completed - Canada, British Columbia ... More >> University of British Columbia Gerontology & Diabetes Research Centre Vancouver, British Columbia, Canada Less <<
NCT00477581 Type 2 Diabetes Mellitus Phase 4 Completed - United States, California ... More >> Research Site Los Angeles, California, United States Research Site Spring Valley, California, United States United States, Florida Research Site Miami, Florida, United States Research Site Pembroke Pines, Florida, United States United States, Illinois Research Site Chicago, Illinois, United States United States, Indiana Research Site Indianapolis, Indiana, United States, 46260 Research Site Indianapolis, Indiana, United States United States, Michigan Research Site Detroit, Michigan, United States United States, Montana Research Site Butte, Montana, United States United States, North Carolina Research Site Winston-Salem, North Carolina, United States United States, Ohio Research Site Cincinatti, Ohio, United States Research Site Marion, Ohio, United States United States, Oregon Research Site Eugene, Oregon, United States Research Site Portland, Oregon, United States United States, South Carolina Research Site Charleston, South Carolina, United States Research Site Greer, South Carolina, United States United States, Texas Research Site Austin, Texas, United States Research Site Corpus Christi, Texas, United States Research Site San Antonio, Texas, United States Less <<
NCT01718093 Type 1 Diabetes Phase 4 Completed - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT01590771 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01590771 - Completed - -
NCT00305604 Type 2 Diabetes Phase 3 Completed - -
NCT00305604 - Completed - -
NCT01488279 Pre-diabetes ... More >>Impaired Fasting Glucose Impaired Glucose Tolerance Less << Not Applicable Completed - United States, Vermont ... More >> University of Vermont Clinical Research Center South Burlington, Vermont, United States, 05403 Less <<
NCT02330406 Dipeptidyl-Peptidase 4 Inhibit... More >>ors LDL Cholesterol Glycosylated Hemoglobin Diabetes Mellitus Coronary Disease Less << Phase 4 Active, not recruiting December 2018 Japan ... More >> Department of Cardiovascular Medicine, Tomishiro Central Hospital Tomishiro, Okinawa, Japan, 901-0243 Less <<
NCT01257464 Cystic Fibrosis Phase 2 Terminated(Lack of recruitment... More >>) Less << - Canada, British Columbia ... More >> University of British Columbia Gerontology & Diabetes Reserach Centre (ViTALITY) Vancouver, British Columbia, Canada, V5Z 1L8 Less <<
NCT00395343 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01741103 Diabetes Type I Not Applicable Unknown September 2013 United States, New York ... More >> 115 Flint Road Recruiting Williamsville, New York, United States, 14221 Contact: Paresh Dandona, MD    716-626-7998    pdandona@kaleidahealth.org Less <<
NCT01859793 Diabetes Athe... More >>rosclerosis Less << Phase 4 Completed - United States, Wisconsin ... More >> Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00395343 - Completed - -
NCT01530178 - Completed - -
NCT01530178 Diabetes Mellitus, Type 1 Phase 4 Completed - United States, New York ... More >> Albert Einstein College of Medicine CRC Bronx, New York, United States, 10461 Less <<
NCT02738879 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01859793 - Completed - -
NCT00642798 Diabetes Mellitus Non-insulin-... More >>dependent Less << Phase 1 Completed - -
NCT01260246 Type 2 Diabetes ... More >> Nonalcoholic Steatohepatitis Less << Not Applicable Terminated(Slow recruitment) - Canada, Ontario ... More >> St. Joseph's Health Care London, Ontario, Canada, N6A 4L6 Less <<
NCT01398592 Diabetes Mellitus Type 2 Phase 4 Completed - Germany ... More >> Novartis Investigative Site Bad Oeynhausen, Germany, 32549 Novartis Investigative Site Berlin, Germany, 12347 Novartis Investigative Site Berlin, Germany, 13597 Novartis Investigative Site Berlin, Germany, 14089 Novartis Investigative Site Celle, Germany, 29221 Novartis Investigative Site Hannover, Germany, 30165 Novartis Investigative Site Hannover, Germany, 30167 Novartis Investigative Site Kassel, Germany, 34117 Novartis Investigative Site Kirchhain, Germany, 35274 Novartis Investigative Site Lehrte, Germany, 31275 Novartis Investigative Site Mülheim, Germany, 45468 Novartis Investigative Site Oberhausen, Germany, 46049 Novartis Investigative Site Osnabrück, Germany, 49080 Novartis Investigative Site Potsdam, Germany, 14469 Novartis Investigative Site Stuttgart, Germany, 70378 Less <<
NCT01488279 - Completed - -
NCT02577016 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02577016 - Completed - -
NCT00832624 - Terminated(Business Reasons) - -
NCT01721382 Cystic Fibrosis Phase 1 Completed - United States, Florida ... More >> Nemours Children's Clinic Jacksonville, Florida, United States, 32207 Less <<
NCT01227460 Type 1 Diabetes Not Applicable Completed - United States, Colorado ... More >> University of Colorado/Barbara Davis Center for Diabetes Aurora, Colorado, United States, 80045 Less <<
NCT02827890 Diabetes Mellitus Type 2 Phase 1 Completed - Korea, Republic of ... More >> Chonbuk National University Hospital Jeonju-si, Korea, Republic of Less <<
NCT00466518 Kidney Transplant ... More >> Type 2 Diabetes Less << Not Applicable Completed - United States, Nebraska ... More >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-1230 Less <<
NCT01195090 Type 2 Diabetes Phase 4 Completed - Taiwan ... More >> Division of Endocrinology and Metabolism, Department of Internal Medicine, Mackay Memorial Hospital Taipei, Taiwan, 10449 Less <<
NCT00740363 Glucose Intolerance Phase 4 Completed - Norway ... More >> Rikshospitalet Medical Center Oslo, Norway, 0027 Less <<
NCT00832624 Diabetes Mellitus Non-insulin-... More >>dependent Less << Phase 4 Terminated(Business Reasons) - -
NCT02263677 Type 2 Diabetes ... More >> Non-alcoholic Fatty Liver Disease Less << Phase 4 Withdrawn(Technical difficulti... More >>es have caused this study to be terminated) Less << - United States, Missouri ... More >> University of Missouri-Columbia: Diabetes Center Columbia, Missouri, United States, 65212 Less <<
NCT01195090 - Completed - -
NCT01408888 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Florida ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Daytona Beach, Florida, United States, 32117 United States, Hawaii For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Honolulu, Hawaii, United States, 96814 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States, 75247 Less <<
NCT00509236 Diabetes Mellitus, Type 2 ... More >> End-Stage Kidney Disease Less << Phase 3 Completed - -
NCT01408888 - Completed - -
NCT02655757 Atherosclerosis ... More >> Type 2 Diabetes Mellitus Less << Phase 4 Completed - China, Beijing ... More >> The General Hospital of PLA Beijing, Beijing, China, 100853 Less <<
NCT00847080 Reactive Hypoglycemia Phase 4 Completed - Mexico ... More >> Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Mexico, DF, Mexico, 14000 Less <<
NCT00509236 - Completed - -
NCT00790205 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00833027 Diabetes Mellitus Phase 4 Completed - -
NCT00686634 Type 2 Diabetes Mellitus Phase 4 Completed - United States, California ... More >> Charles Drew University of Medicine and Science Los Angeles, California, United States, 90059 Less <<
NCT00833027 - Completed - -
NCT00686634 - Completed - -
NCT01336322 Pre-diabetes Phase 2 Recruiting December 2018 Italy ... More >> Department of Endocrinology and Metabolism, University of Pisa Recruiting Pisa, Italy, 56124 Contact: Stefano Del Prato, MD    +39 050 995103    stefano.delprato@med.unipi.it    Sub-Investigator: Graziano Di Cianni, MD Less <<
NCT02318693 Type 2 Diabetes Mellitus Phase 4 Completed - -
NCT00790205 - Completed - -
NCT02192853 Type 2 Diabetes Mellitus Phase 4 Completed - Denmark ... More >> Diabetes Research Division, Department of Endocrinology, Gentofte Hospital Hellerup, Denmark, 2900 Less <<
NCT02513771 HIV-1 Infection Phase 2 Completed - United States, California ... More >> University of Southern California (1201) Los Angeles, California, United States, 90033-1079 UCLA CARE Center CRS (601) Los Angeles, California, United States, 90095 Harbor-UCLA Med. Ctr. CRS (603) Torrance, California, United States, 90502 United States, District of Columbia Whitman Walker Health CRS (31791) Washington, District of Columbia, United States, 20009 United States, Missouri Washington University CRS (2101) Saint Louis, Missouri, United States, 63110 United States, New York Cornell CRS (7804) New York, New York, United States, 10011 Columbia Physicians and Surgeons CRS (30329) New York, New York, United States, 10032 University of Rochester Adult HIV Therapeutic Strategies Network CRS (31787) Rochester, New York, United States, 14642 United States, North Carolina Unc Aids Crs (3201) Chapel Hill, North Carolina, United States, 27516 Greensboro CRS (3203) Greensboro, North Carolina, United States, 27401 United States, Ohio Univ. of Cincinnati CRS (2401) Cincinnati, Ohio, United States, 45267 Case CRS (2501) Cleveland, Ohio, United States, 44106 The Ohio State Univ. AIDS CRS (2301) Columbus, Ohio, United States, 43210 United States, Pennsylvania Hosp. of the Univ. of Pennsylvania CRS (6201) Philadelphia, Pennsylvania, United States, 19104 Pittsburgh CRS (1001) Pittsburgh, Pennsylvania, United States, 15213 United States, Texas Houston AIDS Research Team CRS (31473) Houston, Texas, United States, 77030 Less <<
NCT02318693 - Completed - -
NCT02312063 Diabetes Mellitus, Type 2 Phase 4 Completed - Japan ... More >> Saiseikai Noe Hospital Osaka Osaka, Japan, 536-0001 Kansai Electric Power Hospital Osaka, Japan, 553-0003 Less <<
NCT00696826 Liver Insufficiency Phase 1 Completed - -
NCT00969566 Diabetes Phase 4 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Gyeonggi, Korea, Republic of, 463-707 Less <<
NCT01112670 - Completed - -
NCT01112670 Healthy Phase 4 Completed - United States, Colorado ... More >> University of Colorado Denver Aurora, Colorado, United States, 80045 Less <<
NCT00862719 Leukemia, Myeloid, Acute ... More >> Acute Lymphoblastic Leukemia Myelodysplasia Leukemia, Myelogenous, Chronic Lymphoma, Non-Hodgkin Less << Phase 2 Completed - United States, Indiana ... More >> IU Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT02513771 - Completed - -
NCT03359590 Pharmacological Action Phase 2 Enrolling by invitation July 30, 2019 Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany Less <<
NCT01034111 Type 2 Diabetes Phase 3 Completed - -
NCT00862719 - Completed - -
NCT01970462 Diabetes Mellitus, Type 2 ... More >> Hyperglycemia Less << Phase 4 Terminated(Recruitment) - United States, Ohio ... More >> The Ohio State University Wexner Medical Center Columbus, Ohio, United States, 43203 Less <<
NCT01034111 - Completed - -
NCT01970462 - Terminated(Recruitment) - -
NCT01334229 Type 2 Diabetes Mellitus Phase 3 Completed - Canada ... More >> Laval University Quebec, Canada, G1V 0A6 Less <<
NCT02683525 Graft vs Host Disease ... More >> Hematopoietic Stem Cell Transplantation Less << Phase 2 Recruiting February 28, 2020 United States, Indiana ... More >> Indiana University Health Hospital Recruiting Indianapolis, Indiana, United States, 46202 Contact: Carol Huntley, RN    317-363-9828    chuntley@iupui.edu    Principal Investigator: Sherif Farag, MD, PhD          Indiana University Health Melvin and Bren Simon Cancer Center Recruiting Indianapolis, Indiana, United States, 46202 Contact: Carol Huntley, RN    317-363-9828    chuntley@iupui.edu    Principal Investigator: Sherif Farag, MD, PhD Less <<
NCT00978796 Type 1 Diabetes Phase 4 Completed - United States, Colorado ... More >> Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80010 Less <<
NCT01720264 Acute Myeloid Leukemia ... More >> Acute Lymphoid Leukemia Hematopoetic Myelodysplasia Leukemia, Myelogenous, Chronic Lymphoma, Non-Hodgkin Less << Phase 2 Completed - United States, Indiana ... More >> Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, New York New York Medical College/Westchester Medical Center/Maria Fareri Children's Hosptial Valhalla, New York, United States, 10595 Less <<
NCT01334229 - Completed - -
NCT01095991 Type 2 Diabetes Mellitus Phase 1 Completed - Germany ... More >> Research Site Neuss, Germany Less <<
NCT01686932 Diabetes Mellitus Type 2 Phase 4 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany, 10115 Novartis Investigative Site Berlin, Germany, 13055 Novartis Investigative Site Dortmund, Germany, 44137 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Elsterwerda, Germany, 04910 Novartis Investigative Site Falkensee, Germany, 14612 Novartis Investigative Site Magdeburg, Germany, 39112 Novartis Investigative Site Neuss, Germany, 41460 Novartis Investigative Site Potsdam, Germany, 14469 Novartis Investigative Site Sulzbach-Rosenberg, Germany, 92237 Novartis Investigative Site Wallerfing, Germany, 94574 Less <<
NCT02015910 Type II Diabetes Phase 4 Terminated(Terminated by the s... More >>ponsor due to slow enrollment) Less << - United States, District of Col... More >>umbia Medstar Georgetown University Hospital Washington, District of Columbia, United States, 20007 Less <<
NCT03076112 Type 2 Diabetes Mellitus Phase 3 Recruiting December 30, 2019 Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Seongnam, Gyeonggi, Korea, Republic of, 463-707 Contact: Soo Lim, MD, PHD    82-31-787-7035    limsoo@snu.ac.kr    Contact: Kyoung Min Kim, MD, PHD    82-31-787-7047    kyoungmin02@gmail.com    Principal Investigator: Soo Lim, MD, PHD Less <<
NCT02536248 Type 2 Diabetes Mellitus Phase 3 Active, not recruiting March 31, 2018 Canada, Quebec ... More >> Laval University Quebec City, Quebec, Canada, G1V 0A6 Less <<
NCT02015910 - Terminated(Terminated by the s... More >>ponsor due to slow enrollment) Less << - -
NCT00730275 Type 2 Diabetes Phase 1 Completed - -
NCT00659711 Type 2 Diabetes Not Applicable Unknown December 2013 United States, New York ... More >> 115 Flint Road Buffalo, New York, United States, 14221 Less <<
NCT01512797 Type 2 Diabetes Mellitus Not Applicable Completed - United States, New York ... More >> New York Obesity Nutrition Research Center, Columbia University New York, New York, United States, 10032 Less <<
NCT01785043 DIABETES Mellitus Type 2 Not W... More >>ell Controlled Less << Phase 4 Completed - Spain ... More >> Hospital Clínic de Barcelona Barcelona, Spain, 08036 Less <<
NCT01512797 - Completed - -
NCT00944450 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT02294084 Neoplasms, Adipose Tissue Phase 4 Completed - Netherlands ... More >> Leiden University Medical Center Leiden, Zuid-Holland, Netherlands, 2333 ZA Less <<
NCT00657280 Heart Failure, Congestive Early Phase 1 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00657280 - Completed - -
NCT00730275 - Completed - -
NCT00944450 - Completed - -
NCT02328040 Diabetes Mellitus, Type 1 Phase 1 Completed - United States, New York ... More >> Albert Einstein College of Medicine CRC Bronx, New York, United States, 10461 Less <<
NCT01038648 Type 2 Diabetes Phase 3 Withdrawn December 2014 India ... More >> Dr.Ambady Ramachandran Chennai, Tamil nadu, India, 600 008 Less <<
NCT01686932 - Completed - -
NCT01159847 Type 1 Diabetes Phase 1 Phase 2 Completed - China, Hunan ... More >> Diabetes Center, Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University Changsha, Hunan, China, 410011 Less <<
NCT02900417 Type 2 Diabetes Not Applicable Unknown November 2016 -
NCT02406950 Healthy Phase 3 Unknown August 2015 Korea, Republic of ... More >> Kyung Hee University Hospital Recruiting Seoul, Korea, Republic of, 130-872 Contact: Weon Kim, MD, PhD    2-958-8170 ext 82    mylovekw@hanmail.net    Contact: Jong Shin Woo, MD    2-958-8176 ext 82    snowball77@hanmail.net    Sub-Investigator: Jong Shin Woo, MD Less <<
NCT01600703 - Completed - -
NCT01600703 Hyperlipidemia Phase 2 Phase 3 Completed - Canada, Ontario ... More >> Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 Less <<
NCT02328040 - Completed - -
NCT02377388 Platelet Aggregation During Ac... More >>ute Myocardial Infarction Less << Phase 3 Recruiting December 2019 Brazil ... More >> Heart Institute(InCor)-Acute Coronary Care Unit Recruiting São Paulo, SP, Brazil, 01406000 Contact: Paulo R Genestreti, MD    55 11 2661-5058    paulo.gen@ig.com.br    Principal Investigator: Jose C Nicolau, MD,PhD          Sub-Investigator: Paulo R Genestreti, MD Less <<
NCT00789191 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00789191 - Completed - -
NCT02036515 - Completed - -
NCT03659461 Type 2 Diabetes Mellitus ... More >> PreDiabetes Less << Not Applicable Recruiting January 2020 Malaysia ... More >> Hospital Sultan Ismail Recruiting Johor Bahru, Johor, Malaysia, 81100 Contact: Chong Shiau Chin, MPHARM    +6073565000    shiauchin83@hotmail.com    Contact    +60361455555 Less <<
NCT00699322 Type 2 Diabetes Phase 4 Unknown June 2010 Korea, Republic of ... More >> Kangnam St. Mary's hospital Recruiting Seoul, Korea, Republic of, 137-701 Sub-Investigator: Seung-Hwan Lee, M.D.          Sub-Investigator: Eun-Sook Kim, M.D.          Principal Investigator: Kun-Ho Yoon, M.D., Ph.D. Less <<
NCT00086515 Diabetes Mellitus, Type II Phase 3 Completed - -
NCT00086515 - Completed - -
NCT02741687 Hyperglycemia Phase 4 Completed - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Emory University Hospital Midtown Atlanta, Georgia, United States, 30322 Less <<
NCT00790348 - Unknown - United States, Michigan ... More >> Wayne State University Recruiting Detroit, Michigan, United States, 48201 Contact: Berhane Seyoum, MD    313-745-4008    bseyoum@med.wayne.edu    Principal Investigator: Berhane Seyoum, MD, MPH Less <<
NCT02741687 - Completed - -
NCT01829464 Diabetes Phase 3 Terminated(Due to potential co... More >>ncerns about liver safety (See Detailed Description)) Less << - -
NCT02036515 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00086502 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01829464 - Terminated(Due to potential co... More >>ncerns about liver safety (See Detailed Description)) Less << - -
NCT00086502 - Completed - -
NCT00734474 - Completed - -
NCT01006018 Prediabetic State Not Applicable Terminated(Unanticipated delay... More >>s due to sterilization/stabilization testing of GLP-1.) Less << - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Emory University Hospital Atlanta, Georgia, United States, 30322 Less <<
NCT00700817 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT02941445 Polycystic Ovary Syndrome ... More >> Body Weight Less << Phase 4 Completed - -
NCT00734474 Diabetes Mellitus, Type 2 Phase 2 Phase 3 Completed - -
NCT01169090 Type 2 Diabetes Phase 2 Completed - -
NCT02949193 Type 2 Diabetes Mellitus Phase 3 Completed - Korea, Republic of ... More >> Kangbuk Samsung Medical Center Seoul, Korea, Republic of, 110-746 Less <<
NCT02685345 Type 2 Diabetes Mellitus Phase 2 Completed - Japan ... More >> Yodogawaku, Osaka, Japan, 565-0853 Less <<
NCT01177813 - Completed - -
NCT01177813 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00087516 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00700817 - Completed - -
NCT02338921 Type 2 Diabetes Phase 4 Recruiting December 2018 Korea, Republic of ... More >> Soo Lim Recruiting Seongnam, Gyeonggi, Korea, Republic of, 463-707 Contact: Dong Hwa Lee, MD Less <<
NCT01006018 - Terminated(Unanticipated delay... More >>s due to sterilization/stabilization testing of GLP-1.) Less << - -
NCT00683735 Diabetes Phase 2 Phase 3 Completed - Germany ... More >> Diabeteszentrum Bad Lauterberg Bad Lauterberg, Germany, 37431 Less <<
NCT01519674 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - -
NCT00087516 - Completed - -
NCT00364377 Pre-diabetes Phase 4 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01519674 - Completed - -
NCT00364377 - Completed - -
NCT01930188 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01137812 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01490918 Type-II Diabetes Mellitus Phase 3 Completed - Korea, Republic of ... More >> MedicalExcellence Seoul, Korea, Republic of, 137-701 Less <<
NCT03061214 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Active, not recruiting April 17, 2019 -
NCT01137812 - Completed - -
NCT02043054 Type 2 Diabetes Mellitus ... More >> Cardiovascular Disease Less << Phase 3 Completed - United Kingdom ... More >> University Hospitals of Leicester NHS Trust, Diabetes Research Centre Leicester, Leicestershire, United Kingdom, LE5 4PW Less <<
NCT01856907 - Completed - -
NCT01820104 Healthy Phase 1 Completed - China, Shaanxi ... More >> Department of pharmacy, Xijing Hospital, Fourth Military Medical University Xi'an, Shaanxi, China Less <<
NCT02920918 Heart Failure, Systolic ... More >> Diabetes Mellitus, Type 2 Less << Phase 4 Active, not recruiting March 2019 United States, Virginia ... More >> Virginia Commonwealth University Richmond, Virginia, United States, 23298 Less <<
NCT00939939 Diabetes Mellitus Type 2 Phase 4 Terminated(Recruitment failure... More >>) Less << - Germany ... More >> Medical Dept. 2, Grosshadern, University Munich Munich, Germany, 81377 Less <<
NCT01119846 - Completed - -
NCT01119846 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, Arizona ... More >> GSK Investigational Site Phoenix, Arizona, United States, 85013 United States, California GSK Investigational Site Chula Vista, California, United States, 91910 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27705 United States, Ohio GSK Investigational Site Columbus, Ohio, United States, 43212 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78209 United States, Washington GSK Investigational Site Tacoma, Washington, United States, 98418 Less <<
NCT00094757 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01316835 - Unknown December 2011 Taiwan ... More >> Kaohsiung Chang Gung Memorial Hospita Recruiting Kaohsiung, Taiwan Contact: Ching-Jung Hsieh, MD    886-7-7317123    rose@adm.cgmh.org.tw Less <<
NCT02301806 Type 2 Diabetes Phase 4 Unknown July 2017 Japan ... More >> Dokkyo Medical University Recruiting Mibu, Tochigo, Japan, 321-0293 Contact: Yoshimasa Aso, MD    81-282-86-1111    yaso@dokkyomed.ac.jp    Principal Investigator: Yoshimasa Aso, MD          Recruiting Mibu, Japan Less <<
NCT00371007 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT00650143 Acute Myocardial Infarction Phase 2 Phase 3 Unknown December 2013 Germany ... More >> Clinic of the University of Munich-Grosshadern, Department of Cardiology Recruiting Munich, Germany, 81377 Sub-Investigator: Hans D Theiss, Dr. Less <<
NCT00754988 Diabetes Mellitus Type 2 Phase 3 Completed - -
NCT01709305 Type 2 Diabetes Mellitus Phase 4 Completed - -
NCT02956044 Type2 Diabetes Mellitus Phase 1 Completed - United States, Indiana ... More >> Clinical Research Site Evansville, Indiana, United States, 47710 Less <<
NCT00094757 - Completed - -
NCT01856907 Disorder of Glucose Regulation Phase 4 Completed - United States, Louisiana ... More >> Woman's Hospital Baton Rouge, Louisiana, United States, 70817 Less <<
NCT00696982 Diabetes Mellitus ... More >> Arterial Stiffness Less << Not Applicable Unknown June 2009 Israel ... More >> Department of Internal Medicine A , Research & Development unit Assaf Harofeh Medical Center, Zerifin, affiliated to Sackler School of Medicine, Tel Aviv, Israel Recruiting Zrifin, Israel, 70300 Contact: Shlomit Koren, MD    972-546-888=385    shlomitks@gmail.com    Contact: Shai Efrati, MD    972-577-346-364    efratishai@013.net    Principal Investigator: Shlomit Koren, MD Less <<
NCT02122380 Polycystic Ovary Syndrome Phase 4 Active, not recruiting July 1, 2019 United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT02284893 - Completed - -
NCT01709305 - Completed - -
NCT02284893 Type 2 Diabetes Phase 3 Completed - -
NCT02623998 Type 2 Diabetes Mellitus Phase 3 Active, not recruiting December 2018 Canada, Alberta ... More >> University of Calgary Calgary, Alberta, Canada, T2T 5C7 Canada, Manitoba Health Science Centre Winnipeg, Manitoba, Canada, R3E 3P4 Canada, Ontario McMaster University Hamilton, Ontario, Canada St. Joseph's Hospital London, Ontario, Canada, N6A 4V2 LMC Markham, Ontario, Canada Canada, Quebec Univeristy of Montreal Montreal, Quebec, Canada Less <<
NCT01582308 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT02099110 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02607865 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01046110 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01582308 - Completed - -
NCT01065766 - Completed - -
NCT02683187 Healthy Phase 1 Completed - United States, North Carolina ... More >> Leslie Willis Durham, North Carolina, United States, 27707 Less <<
NCT02099110 - Completed - -
NCT01046110 - Completed - -
NCT01065766 - Completed - -
NCT00481663 Type II Diabetes Mellitus Phase 2 Completed - -
NCT01751321 Type 2 Diabetes Not Applicable Unknown October 2013 -
NCT00770081 Diabetes Mellitus, Type 2 ... More >> Renal Insufficiency Less << Phase 3 Completed - -
NCT00425490 Diabetes Mellitus Type 2 Phase 3 Completed - Israel ... More >> Sheba_Medical_Center Tel Hashomer, Israel Less <<
NCT01341717 Diabetes Mellitus, Type 2 Phase 4 Completed - India ... More >> Jothydev's Diabetes and Research Center Thiruvananthapuram, Kerala, India, 695032 Less <<
NCT00511108 Type 2 Diabetes Mellitus (T2DM... More >>) Less << Phase 1 Completed - -
NCT00722371 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00722371 - Completed - -
NCT00511108 - Completed - -
NCT00729326 Type 2 Diabetes Mellitus Phase 4 Completed - United States, Texas ... More >> Research Site San Antonio, Texas, United States Less <<
NCT01357135 - Completed - -
NCT00729326 - Completed - -
NCT02200991 Type 2 Diabetes Mellitus Phase 4 Completed - Japan ... More >> Investigational Site Number 392-107 Atsugi-shi, Japan Investigational Site Number 392-125 Chiyoda-ku, Japan Investigational Site Number 392-121 Chuoh-ku, Japan Investigational Site Number 392-102 Ichihara-shi, Japan Investigational Site Number 392-103 Kawaguchi-shi, Japan Investigational Site Number 392-114 Kitamoto-shi, Japan Investigational Site Number 392-122 Kobe-shi, Japan Investigational Site Number 392-126 Kumamoto-shi, Japan Investigational Site Number 392-127 Kumamoto-shi, Japan Investigational Site Number 392-101 Kyoto-shi, Japan Investigational Site Number 392-106 Matsudo-shi, Japan Investigational Site Number 392-124 Mitaka-shi, Japan Investigational Site Number 392-108 Mito-shi, Japan Investigational Site Number 392-119 Nerima-ku, Japan Investigational Site Number 392-117 Okayama-shi, Japan Investigational Site Number 392-111 Sagamihara-shi, Japan Investigational Site Number 392-110 Sapporo-shi, Japan Investigational Site Number 392-116 Satsumasendai-shi, Japan Investigational Site Number 392-105 Shizuoka-shi, Japan Investigational Site Number 392-118 Suita-shi, Japan Less <<
NCT01936025 Type 2 Diabetes Mellitus Phase 2 Completed - Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, 41460 Less <<
NCT01357135 - Completed - -
NCT00637273 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02008682 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - China, Beijing ... More >> Novo Nordisk Investigational Site Beijing, Beijing, China, 100071 Novo Nordisk Investigational Site Beijing, Beijing, China, 100700 Novo Nordisk Investigational Site Beijing, Beijing, China, 100853 China, Chongqing Novo Nordisk Investigational Site ChongQing, Chongqing, China, 404000 China, Hebei Novo Nordisk Investigational Site Cangzhou, Hebei, China, 061000 Novo Nordisk Investigational Site Hengshui, Hebei, China, 053000 Novo Nordisk Investigational Site Shijiazhuang, Hebei, China, 050000 Novo Nordisk Investigational Site Shijiazhuang, Hebei, China, 050051 China, Jiangsu Novo Nordisk Investigational Site Nanjing, Jiangsu, China, 210011 Novo Nordisk Investigational Site Nanjing, Jiangsu, China, 210012 Novo Nordisk Investigational Site Nanjing, Jiangsu, China, 210029 Novo Nordisk Investigational Site Suzhou, Jiangsu, China, 215004 Novo Nordisk Investigational Site Wuxi, Jiangsu, China, 214023 Novo Nordisk Investigational Site Zhenjiang, Jiangsu, China, 212001 China, Jiangxi Novo Nordisk Investigational Site Nanchang, Jiangxi, China, 330006 China, Jilin Novo Nordisk Investigational Site Changchun, Jilin, China, 130041 China, Liaoning Novo Nordisk Investigational Site Dalian, Liaoning, China, 116033 Novo Nordisk Investigational Site Shenyang, Liaoning, China, 110021 China, Shandong Novo Nordisk Investigational Site Qingdao, Shandong, China, 266003 China, Shanghai Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200080 Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200092 Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200120 Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200240 Novo Nordisk Investigational Site Shanghai, Shanghai, China, 201199 China Novo Nordisk Investigational Site Beijing, China, 101200 Less <<
NCT00637273 - Completed - -
NCT01907854 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 4 Completed - -
NCT02008682 - Completed - -
NCT02824874 Diabetes Mellitus, Type II Phase 1 Completed - Korea, Republic of ... More >> Chonbuk National University Hospital Jeonju-si, Korea, Republic of Less <<
NCT03267576 Diabetes Mellitus, Type 2 Phase 4 Completed - Mexico ... More >> Consultorio Privado Guadalajara, Mexico, 44150 Investigación Clínica Especializada Guadalajara, Mexico, 44600 Consultorio Privado en Unidad de Patología Clínica Guadalajara, Mexico, 44650 Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán Mexico City, Mexico, 14080 Hospital Universitario 'Dr. Jose Eleuterio Gonzalez' Monterrey, Mexico, 64460 Less <<
NCT00397631 - Completed - -
NCT00397631 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00768651 Type 1 Diabetes Phase 2 Completed - Canada, Alberta ... More >> University of Alberta - Clinical Islet Transplant Program Edmonton, Alberta, Canada, T6G2C8 Less <<
NCT01717911 Type 2 Diabetes Phase 4 Unknown December 2018 Taiwan ... More >> Taipei Veterans General Hospital Recruiting Taipei, Taiwan, 11217 Contact: Harn-Shen Chen, MD, PhD    886-2-28757515    chenhs@vghtpe.gov.tw    Principal Investigator: Harn-Shen Chen, MD, PhD Less <<
NCT00768651 - Completed - -
NCT01441232 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Texas ... More >> Lexicon Investigational Site San Antonio, Texas, United States, 78209 Less <<
NCT00971659 Type 2 Diabetes Phase 1 Completed - Germany ... More >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, 41460 Less <<
NCT00975052 Type 2 Diabetes Phase 1 Completed - -
NCT01907854 - Completed - -
NCT00813228 Diabetes Mellitus Type 1 ... More >> Diabetes Mellitus Type 2 Less << Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01422590 Type 2 Diabetes Mellitus Phase 1 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT03078049 - Completed - United States, Delaware ... More >> Research Site Wilmington, Delaware, United States, 19803 Less <<
NCT02254291 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - Japan ... More >> Novo Nordisk Investigational Site Asahikawa-shi, Hokkaido, Japan, 070 0002 Novo Nordisk Investigational Site Chitose, Hokkaido, Japan, 066-0032 Novo Nordisk Investigational Site Chuo-ku Tokyo, Japan, 103-0027 Novo Nordisk Investigational Site Chuo-ku Tokyo, Japan, 104-0031 Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 103 0027 Novo Nordisk Investigational Site Ebina-shi, Japan, 243 0432 Novo Nordisk Investigational Site Izumisano-shi, Japan, 598 0048 Novo Nordisk Investigational Site Kashiwara-shi, Osaka, Japan, 582 0005 Novo Nordisk Investigational Site Katsushika-ku, Tokyo, Japan, 125 0054 Novo Nordisk Investigational Site Kumamoto-shi,Kumamoto, Japan, 862 0976 Novo Nordisk Investigational Site Naka-shi, Ibaraki, Japan, 311 0113 Novo Nordisk Investigational Site Nishinomiya-shi, Hygo, Japan, 662 0971 Novo Nordisk Investigational Site Oita-shi, Japan, 870 0039 Novo Nordisk Investigational Site Osaka-shi, Osaka, Japan, 553 0003 Novo Nordisk Investigational Site Ota-ku, Tokyo, Japan, 144 0035 Novo Nordisk Investigational Site Ota-ku, Tokyo, Japan Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 060 0062 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 060-0001 Novo Nordisk Investigational Site Shimotsuke-shi, Tochigi, Japan, 329 0433 Novo Nordisk Investigational Site Shinjuku-ku, Tokyo, Japan, 160-0008 Novo Nordisk Investigational Site Suita-shi, Osaka, Japan, 565-0853 Novo Nordisk Investigational Site Takatsuki-shi, Osaka, Japan, 569 1096 Novo Nordisk Investigational Site Tokyo, Japan, 181-0013 Novo Nordisk Investigational Site Yokohama, Kanagawa, Japan, 236-0004 Novo Nordisk Investigational Site Yokohama-shi, Japan, 235 0045 Less <<
NCT01841697 Type 2 Diabetes Phase 3 Completed - -
NCT02254291 - Completed - -
NCT01841697 - Completed - -
NCT01879228 Cystic Fibrosis ... More >> Pancreatic Insufficiency Less << Not Applicable Recruiting December 2018 United States, Pennsylvania ... More >> Children's Hospital of Philadelphia and University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19194 Contact: Christina Kubrak, RRT    267-426-5135       Principal Investigator: Michael M Rickels, MD, MS          Principal Investigator: Andrea Kelly, M.D., M.S Less <<
NCT00721552 Diabetes Mellitus ... More >> Steroid Diabetes Glucocorticoid-induced Diabetes Beta-cell Function Less << Not Applicable Completed - Netherlands ... More >> VUmc Diabetes Center Amsterdam, Noord-Holland, Netherlands, 1081 HV Less <<
NCT00875394 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 3 Completed - -
NCT00957060 Diabetes Mellitus, Type 2 Phase 4 Completed - Guatemala ... More >> Sanofi-Aventis Administrative Office Guatemala City, Guatemala Mexico Sanofi-Aventis Administrative Office Col. Coyoacan, Mexico Less <<
NCT00103857 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00842556 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Texas ... More >> Ppd Development Austin, Texas, United States, 78744 Less <<
NCT00532935 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00103857 - Completed - -
NCT00875394 - Completed - -
NCT00484419 Type 2 Diabetes ... More >> Hyperlipidemia Less << Phase 3 Completed - United States, California ... More >> La Mesa, California, United States Los Angeles, California, United States Los Gatos, California, United States San Antonio, California, United States United States, Florida Chiefland, Florida, United States United States, Indiana Gary, Indiana, United States United States, Maryland Baltimore, Maryland, United States United States, Michigan Dearborn, Michigan, United States W. Bloomfield, Michigan, United States United States, Nevada Las Vegas, Nevada, United States United States, New York Yonkers, New York, United States United States, North Carolina Lexington, North Carolina, United States Winston-Salem, North Carolina, United States United States, Ohio Munroe Falls, Ohio, United States Zaneville, Ohio, United States United States, Oregon Portland, Oregon, United States United States, Pennsylvania Jersey Shore, Pennsylvania, United States United States, South Carolina Clemson, South Carolina, United States United States, Tennessee Harriman, Tennessee, United States United States, Texas Dallas, Texas, United States Less <<
NCT00484419 - Completed - -
NCT01602003 Type 2 Diabetes Mellitus Phase 3 Completed - Korea, Republic of ... More >> LG Life Sciences Seoul, Korea, Republic of, 110-062 Less <<
NCT01610154 Insulin Secretion ... More >> Insulin Resistance Less << Phase 4 Completed - China ... More >> Fuwai Hospital Beijing, China Less <<
NCT00094770 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00532935 - Completed - -
NCT01890629 Type 2 Diabetes Mellitus Phase 4 Completed - Korea, Republic of ... More >> Severance hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT01760447 Type 2 Diabetes Mellitus Phase 3 Active, not recruiting September 13, 2019 -
NCT02849080 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Active, not recruiting April 5, 2019 -
NCT01610154 - Completed - -
NCT01296412 - Completed - -
NCT00094770 - Completed - -
NCT00766441 Diabetes Hypo... More >>glycemia Less << Phase 4 Terminated(inadequate recruitm... More >>ent) Less << - United Kingdom ... More >> Wellcome Trust Clinical Research Facility Manchester, United Kingdom, M13 9NT Less <<
NCT01076088 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01076088 - Completed - -
NCT00993187 Type 2 Diabetes Mellitus Phase 4 Completed - -
NCT01296412 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01096277 Type 2 Diabetes Mellitus Phase 4 Unknown December 2012 Germany ... More >> Hannover Medical School Not yet recruiting Hannover, Germany, 30625 Contact: Sajoscha A. Sorrentino, MD       sorrentino.sajoscha@mh-hannover.de    Principal Investigator: Sajoscha A. Sorrentino, MD Less <<
NCT00993187 - Completed - -
NCT00545584 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << Phase 3 Completed - -
NCT02556918 Hyperglycemia Phase 4 Recruiting March 2019 United States, Georgia ... More >> Grady Health System Recruiting Atlanta, Georgia, United States, 30303 Contact: Guillermo Umpierrez, MD    404-778-1665    geumpie@emory.edu    Emory Univeristy Hospital Midtown Not yet recruiting Atlanta, Georgia, United States, 30308 Contact: Guillermo Umpierrez, MD    404-778-1665    geumpie@emory.edu    Emory University Hospital Recruiting Atlanta, Georgia, United States, 30322 Contact: Guillermo Umpierrez, MD    404-778-1665 Less <<
NCT02226003 - Completed - -
NCT02226003 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00545584 - Completed - -
NCT01409213 - Completed - -
NCT01624116 Diabetes, Type 2 Not Applicable Completed - Pakistan ... More >> Endocrinology Unit & Diabetes Management Centre, Services Hospital. Lahore, Pakistan Less <<
NCT01409213 - Completed - -
NCT00860288 Diabetes Mellitus, Type 2 Phase 2 Phase 3 Completed - -
NCT02946632 Diabetes Mellitus, Type II Phase 3 Not yet recruiting December 2019 Korea, Republic of ... More >> Korea University Anam Hospital Seoul, Korea, Republic of Less <<
NCT01278485 - Completed - -
NCT01285076 - Completed - Taiwan ... More >> Merck Sharp & Dohme (I.A.) Corp. Taipei, Taiwan, 106 Less <<
NCT01285076 - Completed - -
NCT02743260 Healthy Phase 4 Unknown December 2017 Germany ... More >> Department of Pharmacology I, University Hospital Cologne Cologne, NRW, Germany, 50931 Less <<
NCT02882477 Diabetes Mellitus ... More >> Iron Metabolism Disorders Gastroduodenal Ulcer Optic Atrophy Sensorineural Hearing Loss Platelet Dysfunction Less << Phase 2 Phase 3 Unknown December 2018 Israel ... More >> Hadassah medical center Recruiting Jerusalem, Israel Contact: David Zangen, Professor    0097507874488    zanegnd@hadassah.org.il    Contact: Ulla Najwa Abdulhag, MD    0097505172866    najwa.ped@gmail.com Less <<
NCT01794143 Type 2 Diabetes ... More >> Comparative Effectiveness of Glycemia-lowering Medications Less << Phase 3 Active, not recruiting - -
NCT01588587 - Unknown December 2017 Japan ... More >> Kurume University Not yet recruiting Kurume, Fukuoka, Japan, 830-0111 Contact: Sho-ichi Yamagishi, MD    +81-942-31-7873    shoichi@med.kurume-u.ac.jp    Sub-Investigator: Sho-ichi Yamagishi, MD          Nagaoka Red Cross Hospital Not yet recruiting Nagaoka, Niigata, Japan, 940-2085 Contact: Kyuzi Kamoi, MD    +81-0258-28-3600    kkam-int@echogo.ne.jp    Principal Investigator: Kyuzi Kamoi, MD          Sub-Investigator: Sho-ichi Yamagishi, MD Less <<
NCT01106690 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00837759 Diabetes Mellitus Type 1 ... More >> Autoimmune Diabetes Less << Phase 2 Terminated(Changes to study pe... More >>rsonnel.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01545024 - Unknown January 2013 Japan ... More >> Nagaoka Red Cross Hospital Recruiting Nagaoka, Niigata, Japan, 940-2085 Contact: Kyuzi Kamoi, MD    +81-0258-28-3600    kkam-int@echigo.ne.jp    Principal Investigator: Kyuzi Kamoi, MD Less <<
NCT02653131 Short Bowel Syndrome Phase 4 Unknown December 2017 Poland ... More >> Stanley Dudrick's Memorial Hospital Recruiting Skawina, Poland, 32-050 Contact: Stanislaw Klek, Assoc. Prof.    +48604293566    klek@poczta.onet.pl    Principal Investigator: Stanislaw Klek, Assoc. Prof. Less <<
NCT01278485 - Completed - -
NCT03646721 Diabetes Mellitus, Type 2 Phase 1 Recruiting October 7, 2019 United States, California ... More >> Clinical Site Recruiting Chula Vista, California, United States, 91911 Contact: Julie Willard, MD    619-943-6328 ext 217    Julie.Willard@prosciento.com Less <<
NCT01128621 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, California ... More >> GSK Investigational Site Chula Vista, California, United States, 91910 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 Less <<
NCT00837759 - Terminated(Changes to study pe... More >>rsonnel.) Less << - -
NCT01035879 Diabetes Phase 2 Completed - United States, California ... More >> Impact Clinical Trials Los Angeles, California, United States, 90036 United States, Nevada Nevada Alliance Against Diabetes Las Vegas, Nevada, United States, 89101 United States, New York United Medical Associates Binghamton, New York, United States, 13901 United States, Texas dgd Research, Inc., a Cetero Research Co. San Antonio, Texas, United States, 78229 Georgia Healthy Life Clinical Diagnostic Center Tbilisi, Georgia, 0144 Georgian Diabetes Center Tbilisi, Georgia, 0159 Medulla Chemotherapy and Immunotherapy Clinic Tbilisi, Georgia, 0186 India Bharti Research Institute of Diabetes and Endocrinology Karnal, Haryana, India, 132001 Diabetes Thyroid Hormone Research Institute Pvt Ltd Indore, M.p., India, 452001 Gandhi Endocrinology & Diabetes Centre Ramdaspeth, Nagpur, India, 10 Gokula Metropolis Research, MS Ramaiah Memorial Hospital Bangalore, India, 560 054 Medisys Clinisearch India Pvt Ltd Bangalore, India, 560043 Hormone Care Research Centre Ghaziabad, India, 201002 Bangalore Endocrinology & Diabetes Research Centre Malleshwaram, India, 560 003 Less <<
NCT01081834 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT03101930 Obesity PreDi... More >>abetes Less << Phase 4 Recruiting September 1, 2021 United States, Tennessee ... More >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Dustin Mayfield, RN    615-343-8701       Contact: Nancy J Brown, MD    6153438701    nancy.j.brown@vanderbilt.edu Less <<
NCT00881530 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT01619332 Type II Diabetes Phase 1 Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Chula Vista, California, United States, 91910 United States, Florida Novartis Investigative Site Miami, Florida, United States, 33126 Novartis Investigative Site Orlando, Florida, United States, 32809 United States, Ohio Novartis Investigative Site Cincinnati, Ohio, United States, 45227 United States, Tennessee Novartis Investigative Site Knoxville, Tennessee, United States, 37920 United States, Texas Novartis Investigative Site San Antonio, Texas, United States, 78209 Less <<
NCT01128621 - Completed - -
NCT01081834 - Completed - -
NCT00780715 - Completed - -
NCT00780715 Diabetes Mellitus, Type 2 Phase 4 Completed - United Kingdom ... More >> Ninewells Hospital & Medical School Dundee, United Kingdom, DD1 9SY Less <<
NCT03738878 Hypertension Phase 4 Recruiting December 31, 2020 United States, Tennessee ... More >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37205 Contact: Nancy J Brown, MD    615-343-8701       Contact: Dustin Mayfield, RN    615-343-8701 Less <<
NCT03717688 Diabetes Hear... More >>t Failure Less << Phase 4 Recruiting January 31, 2019 Denmark ... More >> University of Copenhagen Recruiting Copenhagen, Denmark, 2100 Contact: Peter Plomgaard, MD, PhD    35451397    Peter.Plomgaard@regionh.dk    Principal Investigator: Peter Plomgaard, MD, PhD Less <<
NCT01073826 Diabetes Mellitus, Type 2 ... More >> Obesity Less << Not Applicable Completed - Switzerland ... More >> University Hospital Zurich Zurich, Switzerland Less <<
NCT01106690 - Completed - -
NCT01744236 Type 2 Diabetes Phase 4 Completed - Netherlands ... More >> VU University Medical Center Amsterdam, Netherlands, 1081HV Less <<
NCT02639637 - Completed - -
NCT00881530 - Completed - -
NCT00998686 Type 2 Diabetes Mellitus Phase 3 Terminated November 2011 -
NCT01376323 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, Alabama ... More >> GSK Investigational Site Anniston, Alabama, United States, 36207 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 GSK Investigational Site Miramar, Florida, United States, 33025 France GSK Investigational Site Nantes cedex 01, France, 44093 GSK Investigational Site Pierre-Bénite Cedex, France, 69495 GSK Investigational Site Rennes Cedex, France, 35046 GSK Investigational Site Rueil-Malmaison, France, 92502 Spain GSK Investigational Site Alicante, Spain, 03114 GSK Investigational Site Badalona, Spain, 08916 GSK Investigational Site Granada, Spain, 18004 GSK Investigational Site Madrid, Spain, 28046 United Kingdom GSK Investigational Site Edinburgh, Midlothian, United Kingdom, EH4 2XU GSK Investigational Site Cambridge, United Kingdom, CB2 0GG GSK Investigational Site Coventry, United Kingdom, CV2 2DX GSK Investigational Site Newcastle upon Tyne, United Kingdom, NE1 4LP Less <<
NCT02647320 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT01475461 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT02639637 Type 2 Diabetes Mellitus Phase 4 Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT02077946 - Completed - Sweden ... More >> Novo Nordisk Investigational Site Malmö, Sweden, 202 15 Less <<
NCT00760344 Diabetes Mellitus Phase 2 Completed - -
NCT00806520 - Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Minnesota International Diabetes Center Minneapolis, Minnesota, United States, 55416 United States, Nevada Palm Medical Group Las Vegas, Nevada, United States, 89148 United States, North Carolina University of North Carolina Diabetes Care Center Durham, North Carolina, United States, 27713 United States, Washington Rockwood Clinic Spokane, Washington, United States, 99202 Less <<
NCT00958269 Type 2 Diabetes Mellitus ... More >> Renal Impairment Less << Phase 3 Terminated(Technical/operation... More >>al issues) Less << November 2011 -
NCT00984867 Type 2 Diabetes Phase 3 Completed - -
NCT02940184 Physiology Not Applicable Recruiting October 2018 Denmark ... More >> Department of Surgery C, Rigshospitalet Recruiting Copenhagen, Denmark, 2100 Contact: Simon Veedfald, MD    +45 41 10 25 95       Contact: Lars Bo Svendsen, Dr.Med.Sci    +45 35 45 21 22    Lars.Bo.Svendsen@regionh.dk    Principal Investigator: Simon Veedfald, MD Less <<
NCT00984867 - Completed - -
NCT01376323 - Completed - -
NCT01089790 Diabetes Mellitus, Type 2 Phase 3 Terminated - -
NCT01093651 Diabetes Insu... More >>lin Resistance Less << Phase 2 Phase 3 Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT02315287 Type 2 Diabetes Phase 4 Recruiting December 2018 Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Seongnam, Gyeonggi, Korea, Republic of, 463-707 Contact: Soo Lim, MD, PHD    82-31-787-7035    limsoo@snu.ac.kr    Contact: Eu Jeong Ku, MD    82-31-787-6232    eujeong.ku@gmail.com    Principal Investigator: Soo Lim, MD, PHD Less <<
NCT02647320 - Completed - -
NCT00881543 Diabetes Type 2 Not Applicable Completed - Brazil ... More >> University of São Paulo General Hospital São Paulo, Brazil Less <<
NCT01093651 - Completed - -
NCT02336659 Severe Obesity Not Applicable Completed - Denmark ... More >> Hvidovre University Hospital Hvidovre, Denmark, DK-2650 Less <<
NCT02697253 Obesity Phase 2 Active, not recruiting December 2020 United States, New York ... More >> Columbia University Medical Center - Russ Berrie Building New York, New York, United States, 10032 Less <<
NCT01475461 - Completed - -
NCT02188186 Type 2 Diabetes Phase 4 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Gyeonggi, Korea, Republic of, 463-707 Less <<
NCT02802644 Acute Coronary Syndrome ... More >> Diabetes Mellitus, Type 2 Less << Phase 4 Recruiting - Korea, Republic of ... More >> Keimyung University Hospital Not yet recruiting Daegu, Korea, Republic of Principal Investigator: Chang-Wook Nam, MD, PhD          Chonnam National University Hospital Not yet recruiting Gwangju, Korea, Republic of Principal Investigator: Young Joon Hong, MD, PhD          Jeju National University Hospital Not yet recruiting Jeju, Korea, Republic of Principal Investigator: Ki-Seok Kim, MD, PhD          Chung-Ang University Hospital Recruiting Seoul, Korea, Republic of, 06973 Principal Investigator: Sang-Wook Kim, MD, PhD          Korea University Guro Hospital Not yet recruiting Seoul, Korea, Republic of Principal Investigator: Seung-Woon Rha, MD, PhD          Ajou University Hospital Not yet recruiting Suwon, Korea, Republic of Principal Investigator: So-Yeon Choi, MD, PhD Less <<
NCT02653209 Type 2 Diabetes Phase 4 Recruiting December 2019 United Kingdom ... More >> Exeter Clinical Research Facility Recruiting Exeter, United Kingdom, EX2 5DW Contact: Catherine Angwin    01392408185    C.Angwin@exeter.ac.uk    Contact: Andrew Hattersley    +441392 408231    A.T.Hattersley@exeter.ac.uk    Principal Investigator: Andrew Hattersley Less <<
NCT01660386 Type 2 Diabetes Phase 4 Unknown March 2013 China ... More >> Shanghai Jiao Tong University School of Medicine Recruiting Shanghai, China, 200021 Contact: Guang Ning, MD,PHD    +8621-64370045 ext 665340    guangning@medmail.com.cn    Principal Investigator: Guang Ning, MD,PHD Less <<
NCT02689362 Diabetes Mellitus, Type 2 Phase 2 Completed - Brazil ... More >> Centro de Estudos em Diabetes e Hipertensão Fortaleza, Ceará, Brazil Hospital Universitário João de Barros Barreto - HUJBB Belém, Pará, Brazil CCBR Brasil Centro de Pesquisas e Analises Clinicas Ltda Rio de Janeiro, Brazil Centro de Pesquisa Clínica em Diabetes - UNIFESP São Paulo, Brazil CEPIC - Centro Paulista de Investigação Clínica São Paulo, Brazil Clinica de Endocrinologia e Metabologia LTDA São Paulo, Brazil CPCLIN - Centro de Pesquisas Clinicas LTDA São Paulo, Brazil HCFMUSP São Paulo, Brazil IMA - Instituto de Pesquisa Clínica e Medicina Avançada Ltda São Paulo, Brazil IPEC - Instituto de Pesquisa Clínica Ltda São Paulo, Brazil Less <<
NCT02405260 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, Arizona ... More >> Mesa, Arizona, United States, 85213 Tuscon, Arizona, United States, 85741 United States, California Canoga Park, California, United States, 91303 Huntington Park, California, United States, 90255 Los Angeles, California, United States, 90056 West Hills, California, United States, 91307 United States, Colorado Centennial, Colorado, United States, 80112 Littleton, Colorado, United States, 80127 United States, Connecticut Waterbury, Connecticut, United States, 06708 United States, Florida West Palm Beach, Florida, United States, 33409 United States, Illinois Gurnee, Illinois, United States, 60031 United States, Indiana Evansville, Indiana, United States, 47725 United States, Minnesota Rochester, Minnesota, United States, 55905 United States, North Carolina Greensboro, North Carolina, United States, 27408 United States, South Carolina Moncks Corner, South Carolina, United States, 29461 United States, Texas San Antonio, Texas, United States, 78209 San Antonio, Texas, United States, 78229 Schertz, Texas, United States, 78154 United States, Virginia Norfolk, Virginia, United States, 23507 United States, Washington Richland, Washington, United States, 99352 Less <<
NCT02130687 Type 2 Diabetes Mellitus ... More >> Hypertension Less << Not Applicable Recruiting June 2020 United States, Tennessee ... More >> Vanderbilt University Recruiting Nashville, Tennessee, United States, 37232 Contact: Jessica R Wilson, M.D.       jessica.r.wilson@vanderbilt.edu    Contact: Scott Hubers, M.D.       scott.hubers@vanderbilt.edu    Principal Investigator: Nancy J Brown, M.D.          Sub-Investigator: Jessica Devin, M.D.          Sub-Investigator: Jessica R Wilson, M.D.          Sub-Investigator: Claudia E Ramirez, M.D.          Sub-Investigator: Scott Hubers, M.D. Less <<
NCT02111096 Diabetes Mellitus, Type 2 Phase 2 Terminated(The overall benefit... More >>-risk profile did not support continued development of LY2409021 for type 2 diabetes.) Less << - -
NCT00964184 Diabetes Mellitus, Type 2 Phase 4 Completed - India ... More >> Fortis Flt Lt Rajan Dhall Hospital New Delhi, Delhi, India, 110070 Less <<
NCT00716092 Diabetes Mellitus, Type 2 Phase 2 Completed - Germany ... More >> 1218.37.49003 Boehringer Ingelheim Investigational Site Berlin, Germany 1218.37.49002 Boehringer Ingelheim Investigational Site Mainz, Germany 1218.37.49001 Boehringer Ingelheim Investigational Site Neuss, Germany Less <<
NCT01235819 Type 1 Diabetes Phase 4 Completed - India ... More >> Command Hospital Lucknow, UP, India, 226002 Less <<
NCT01471808 Diabetes Mellitus, Type 2 Phase 4 Enrolling by invitation December 2021 -
NCT02089438 Type 2 Diabetes Phase 4 Completed - Sweden ... More >> Clinical Research Department Lund, Sweden, 22185 Less <<
NCT00795275 Obesity Not Applicable Completed - United States, Colorado ... More >> University of Colorado Denver Aurora, Colorado, United States, 80045 Less <<
NCT02111096 - Terminated(The overall benefit... More >>-risk profile did not support continued development of LY2409021 for type 2 diabetes.) Less << - -
NCT03593135 Randomized Controlled Trial ... More >> Diabetes Mellitus Less << Not Applicable Completed - Pakistan ... More >> Shaikh Zayed Medical Complex Lahore, Punjab, Pakistan, 54000 Less <<
NCT03233178 - Completed - Canada, Ontario ... More >> LMC Brampton Brampton, Ontario, Canada, L6S 0C9 Less <<
NCT00838903 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00838903 - Completed - -
NCT00716092 - Completed - -
NCT01341795 - Unknown - Korea, Republic of ... More >> Ajou University School of Medicine Recruiting Suwon, Gyeonggi, Korea, Republic of, 433-721 Contact: Doo-Yeoun Cho, MD    +82-31-219-4271    dooycho@ajou.ac.kr    Sub-Investigator: Young-Sang Kim, MD Less <<
NCT01140438 Diabetes Not Applicable Active, not recruiting December 2018 Norway ... More >> Valdemar Grill Trondheim, Norway, 7006 Less <<
NCT02127047 Diabetes Mellitus Type 1 Phase 2 Completed - Switzerland ... More >> University Hospital Basel Basel, Switzerland, 4031 Less <<
NCT02202161 - Completed - -
NCT02567994 Type 2 Diabetes Mellitus Phase 3 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT01193296 Type 2 Diabetes Mellitus Phase 4 Completed - France ... More >> Investigative Site Bondy, France Investigative Site Corbeil, France Investigative Site Marseille, France Investigative Site Nancy, France Investigative Site Paris, France Investigative Site Toulouse, France Investigative Site Venissieux, France Less <<
NCT02202161 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, California ... More >> GSK Investigational Site Chula Vista, California, United States, 91910 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 United States, Maryland GSK Investigational Site Baltimore, Maryland, United States, 21225 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78209 Less <<
NCT00642278 Diabetes Mellitus, Type II ... More >> Diabetes Mellitus, Non Insulin Dependent Less << Phase 2 Completed - -
NCT00747383 Type 2 Diabetes Mellitus Not Applicable Completed - United Kingdom ... More >> Royal Bournemouth Hospital Bournemouth, Dorset, United Kingdom, BH7 7DW Less <<
NCT01701973 Obesity Phase 4 Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT00642278 - Completed - -
NCT01701973 - Completed - -
NCT01847144 Type 2 Diabetes Phase 4 Completed - United Kingdom ... More >> NIHR Exeter Clinical Research Facility, Royal Devon & Exeter NHS Foundation Trust Exeter, Devon, United Kingdom, EX2 5DW Less <<
NCT01338870 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT01332370 - Completed - -
NCT02363335 Healthy Volunteers Phase 1 Completed - United States, Maryland ... More >> National Institute of Aging, Clinical Research Unit Baltimore, Maryland, United States, 21224 Less <<
NCT01338870 - Completed - -
NCT01289990 - Completed - -
NCT03108521 Diabetes Mellitus Phase 4 Recruiting March 2019 China, Sichuan ... More >> Sichuan provincial people's hospital Recruiting Chengdu, Sichuan, China, 610000 Contact: Enwu Long, Master    +86 2887393316    dragon984169@126.com Less <<
NCT02386943 Type 2 Diabetes Phase 4 Unknown March 2015 China ... More >> Shanghai Jiao Tong University School of Medicine Recruiting Shanghai, China Contact: Ning Guang, MD,PHD Less <<
NCT02406443 Type 2 Diabetes Phase 4 Completed - Canada, Ontario ... More >> University Health Network - Division of Nephrology Toronto, Ontario, Canada, M5G 2N2 Less <<
NCT03602638 Atherosclerosis Type 2 Diabete... More >>s Mellitus Dipeptidyl Peptidase-4 Inhibitor GLP-1 Less << Phase 4 Not yet recruiting December 1, 2020 -
NCT01289990 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT02406443 - Completed - -
NCT01106677 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01336738 Diabetes, Type 2 Phase 2 Completed - -
NCT00749190 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT01106677 - Completed - -
NCT01336738 - Completed - -
NCT02628392 Type2 Diabetes Mellitus Not Applicable Completed - Japan ... More >> Heishinkai Medical Group Incorporated OCROM Clinic Suita-shi, Osaka, Japan Less <<
NCT01272583 Type 1 Diabetes ... More >> Hypoglycemia Less << Not Applicable Completed - Netherlands ... More >> Academic Medical Center Amsterdam, Noord Holland, Netherlands, 1100DD Less <<
NCT01272583 - Completed - -
NCT00631488 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT00106704 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00106704 - Completed - -
NCT00749190 - Completed - -
NCT01933672 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Florida ... More >> Avail Clinical Research, LLC DeLand, Florida, United States, 32720 Miami Research Associates, Inc. South Miami, Florida, United States, 33143 MRA Clinical Research, LLC South Miami, Florida, United States, 33143 United States, North Carolina High Point Clinical Trials Center, LLC High Point, North Carolina, United States, 27265 United States, Ohio Community Research Cincinnati, Ohio, United States, 45255 United States, Texas Clinical Trials of Texas, Inc San Antonio, Texas, United States, 78229 Diabetes and Glandular Disease Clinic San Antonio, Texas, United States, 78229 United States, Wisconsin Spaulding Clinical Research, LLC West Bend, Wisconsin, United States, 53095 Less <<
NCT02452632 Type 2 Diabetes Mellitus Phase 3 Completed - Korea, Republic of ... More >> Site KR00002 Busan, Korea, Republic of Site KR00003 Busan, Korea, Republic of Site KR00007 Daegu, Korea, Republic of Site KR00011 Daegu, Korea, Republic of Site KR00019 Dong Gu Gwangju, Korea, Republic of Site KR00008 Gangwon-do, Korea, Republic of Site KR00018 Gyeonggi-do, Korea, Republic of Site KR00022 Gyeonggi-do, Korea, Republic of Site KR00014 Incheon, Korea, Republic of Site KR00020 Jeollabuk-do, Korea, Republic of Site KR00021 Kyungsangnam-do, Korea, Republic of Site KR00001 Seoul, Korea, Republic of Site KR00004 Seoul, Korea, Republic of Site KR00005 Seoul, Korea, Republic of Site KR00006 Seoul, Korea, Republic of Site KR00009 Seoul, Korea, Republic of Site KR00010 Seoul, Korea, Republic of Site KR00012 Seoul, Korea, Republic of Site KR00013 Seoul, Korea, Republic of Site KR00016 Seoul, Korea, Republic of Site KR00017 Seoul, Korea, Republic of Site KR00015 Suwon, Korea, Republic of Less <<
NCT00418366 Renal Insufficiency ... More >> Hemodialysis Less << Phase 1 Completed - -
NCT00947011 - Terminated(PI left JHU) - -
NCT00947011 Glucose Homeostasis Phase 2 Terminated(PI left JHU) - United States, Maryland ... More >> Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States, 21224 Less <<
NCT00673894 Type 2 Diabetes Phase 1 Unknown June 2010 Australia, New South Wales ... More >> Clinical Research Facility Recruiting Sydney, New South Wales, Australia, 2010 Contact: Dr J Greenfield, FRACP    612-9295-8100 ext 8217    j.greenfield@garvan.org.au    Principal Investigator: Jerry Greenfield, FRACP Less <<
NCT01937598 - Completed - -
NCT01937598 Type 2 Diabetes Phase 3 Completed - Germany ... More >> Diabeteszentrum Bad Lauterberg Bad Lauterberg, Germany, 37431 Less <<
NCT02025907 - Completed - -
NCT01933672 - Completed - -
NCT01059825 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT01855087 - Completed - Japan ... More >> Takai Naika Clinic Kamakura, Kanagawa, Japan, 247-0056 Less <<
NCT01895569 Type 2 Diabetes Mellitus Phase 4 Unknown June 2016 Italy ... More >> IRCCS Policlinico S. Matteo Foundation Recruiting Pavia, Italy, 27100 Contact: Giuseppe Derosa, MD, PhD       giuseppe.derosa@unipv.it    Contact: Pamela Maffioli, MD       pamelamaffioli@hotmail.it    Principal Investigator: Giuseppe Derosa, MD, PhD          Sub-Investigator: Pamela Maffioli, MD Less <<
NCT00976261 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Florida ... More >> GSK Investigational Site Miami, Florida, United States, 33169 United States, Louisiana GSK Investigational Site Baton Rouge, Louisiana, United States, 70808 United States, Ohio GSK Investigational Site Cincinnati, Ohio, United States, 45212 France GSK Investigational Site Gières, France, 38610 GSK Investigational Site Rueil-Malmaison, France, 92502 Germany GSK Investigational Site Neuss, Nordrhein-Westfalen, Germany, 41460 GSK Investigational Site Berlin, Germany, 14050 GSK Investigational Site Hamburg, Germany, 22769 United Kingdom GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom, CB2 2GG Less <<
NCT01059825 - Completed - -
NCT00411411 Type 2 Diabetes Phase 3 Completed - Denmark ... More >> Gentofte Hospital Hellerup, Denmark, 2900 Less <<
NCT00631488 - Completed - -
NCT00411411 - Completed - -
NCT02749032 Type 2 Diabetes Phase 1 Completed - Germany ... More >> Diabeteszentrum Bad Lauterberg Bad Lauterberg, Niedersachsen, Germany, 37431 Less <<
NCT01824264 Type 2 Diabetes Mellitus Phase 2 Withdrawn November 2016 -
NCT01413542 Hypertension ... More >>Diabetes Type 2 Less << Not Applicable Completed - United States, Tennessee ... More >> Vanderbilt University- General Clinic Research Center Nashville, Tennessee, United States, 37232 Less <<
NCT02025907 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT01413542 - Completed - -
NCT03492580 - Completed - United States, New Jersey ... More >> Janssen Investigative Site Titusville, New Jersey, United States, 08560 Less <<
NCT02333591 Coronary Microvascular Dysfunc... More >>tion Less << Phase 4 Recruiting November 2018 Denmark ... More >> Department of Research in Endocrinology, Bispebjerg University Hospital Recruiting Copenhagen, Denmark, 2400 Contact: Malin Nilsson, MD    +4540259871    mnil0028@regionh.dk    Contact: Mette Zander, associated prof.    +4551543686    m.zander@dadlnet.dk Less <<
NCT02312427 Heart Failure ... More >> Diabetes Mellitus Less << Phase 4 Completed - Japan ... More >> Mitsui Memorial Hospital Taito-ku, Tokyo, Japan Less <<
NCT01077323 - Completed - United States, Massachusetts ... More >> Research Site Waltham, Massachusetts, United States Less <<
NCT01077323 - Completed - -
NCT03746769 Diabetes Mellitus, Type 1 Phase 1 Phase 2 Not yet recruiting December 2023 United States, California ... More >> City of Hope Medical Center Not yet recruiting Duarte, California, United States, 91010 Principal Investigator: Fouad Kandeel, MD, PhD Less <<
NCT01974544 Type 2 Diabetes Not Applicable Unknown December 2016 Chile ... More >> Pontificia Universidad Católica de Chile Recruiting Santiago, Región Metropolitana, Chile, 8330033 Contact: Castillo Alejandra, Nurse    56223543527    macastia@uc.cl    Contact: Vega Andrea, Nurse    56223543879    abvega@uc.cl    Principal Investigator: Boza Camilo, MD surgeon          Sub-Investigator: Valderas Juan Patricio, MD          Sub-Investigator: Arrese Marco, MD Internist          Sub-Investigator: Muñoz Rodrigo, MD Less <<
NCT02528019 Effects of the DPP-4 Inhibitor... More >>s or SGLT2 Inhibitors on the Protective Actions for Diabetic Complications Less << Phase 4 Unknown August 2018 Japan ... More >> Kurume University Hospital Recruiting Kurume city, Japan, 830-0011 Contact: Nobuhiro Tahara, MD, PhD    +81-942-31-7580    ntahara@med.kurume-u.ac.jp    Contact: Sho-ichi Yamagishi, MD, PhD    +81-942-31-7562       Principal Investigator: Nobuhiro Tahara, MD, PhD Less <<
NCT02456428 - Completed - Canada, Quebec ... More >> Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 Less <<
NCT02476760 - Completed - Canada, Quebec ... More >> Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 Less <<
NCT02368704 - Unknown November 2016 France ... More >> Saint-Louis Hospital Paris, France, 75010 Less <<
NCT02244164 Type 2 Diabetes ... More >> Incretinomimetics Pancreas Less << Not Applicable Recruiting - Belgium ... More >> Gastroenterology Department Erasme Hospital Recruiting Brussels, Belgium, 1070 Contact: Vincent Huberty, MD    +3225553715    vincent.huberty@erasme.ulb.ac.be Less <<
NCT00950534 Diabetes Mellitus, Type 2 Phase 4 Terminated(due to poor recruit... More >>ment) Less << - Australia ... More >> Sanofi-Aventis Administrative Office Macquarie Park, Australia Less <<
NCT02610088 Diabetes Phase 4 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Gyeonggi, Korea, Republic of, 463-707 Less <<
NCT03014479 Type 2 Diabetes Phase 4 Completed - Japan ... More >> Nagoya, Aichi, Japan Kanra, Gunma, Japan Kobe, Hyogo, Japan Koga, Ibaraki, Japan Kawasaki, Kanagawa, Japan Sagamihara, Kanagawa, Japan Yamato, Kanagawa, Japan Sendai, Miyagi, Japan Kashihara, Nara, Japan Kashiwara, Osaka, Japan Suita, Osaka, Japan Okegawa, Saitama, Japan Oyama, Tochigi, Japan Adachi-ku, Tokyo, Japan Chuo-ku, Tokyo, Japan Edogawa-ku, Tokyo, Japan Musashino, Tokyo, Japan Oota-ku, Tokyo, Japan Shibuya-ku, Tokyo, Japan Shinagawa-ku, Tokyo, Japan Shinjuku-ku, Tokyo, Japan Shinjyuku-ku, Tokyo, Japan Osaka, Japan Less <<
NCT01162772 - Unknown - Austria ... More >> Medical University of Viemma Recruiting Vienna, Austria, 1090 Contact: Jeanette Strametz-Juranek, MD    0043140400 ext 4618    jeanette.strametz-juranek@meduniwien.ac.at    Contact: Alexandra Kautzky-Willer, MD    0140400 ext 4316    alexandra.kautzky-willer@meduniwien.ac.at    Principal Investigator: Jeanette Strametz-Juranek, MD          Principal Investigator: Alexandra Kautzky-Willer, MD          Sub-Investigator: Alia Sabri, MD          Sub-Investigator: Lana Kosi, MD Less <<
NCT02130778 Sodium Excretion by Urination Early Phase 1 Completed - Croatia ... More >> University Hospital Centre Zagreb, Croatia, 10 000 University hospital Centre Zagreb Zagreb, Croatia, 10000 Less <<
NCT00426413 - Completed - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Less <<
NCT02280174 Type 2 Diabetes Phase 4 Unknown October 2016 Argentina ... More >> National University of Formosa Recruiting Formosa, Argentina, 3600 Contact: Juan Pa Nogueira, MD/PhD    00543704425447    nogueirajuanpatricio@gmail.com Less <<
NCT03146208 - Not yet recruiting January 20, 2019 -
NCT00684528 Diabetes Type 2 Phase 3 Unknown December 2012 Israel ... More >> Clalit Health services center Recruiting Tel Aviv, Israel, 62098 Contact: Zinger    972-5062-63652       Principal Investigator: Zinger Joel, MD Less <<
NCT02725502 Type 1 Diabetes Mellitus Not Applicable Unknown May 2016 India ... More >> Department of Endocrinology, PGIMER Recruiting Chandigarh, India, 160012 Contact: Snajay Kr Bhadada, MD, DM       bhadadask@rediffmail.com    Contact: Soham Mukherjee, MD    9914743222    drsoham.mukherjee@gmail.com    Principal Investigator: sanjay Kr Bhadada, MD, DM Less <<
NCT00901979 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT02475499 - Completed - Canada, Quebec ... More >> Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 Less <<
NCT02138097 - Completed - United States, Massachusetts ... More >> 1218.161.1 Boehringer Ingelheim Investigational Site Boston, Massachusetts, United States Less <<
NCT01944618 - Terminated() - Australia, Victoria ... More >> Local Institution Clayton, Victoria, Australia, VIC 3168 Less <<
NCT02138097 - Completed - -
NCT01269996 Type 2 Diabetes Mellitus Phase 4 Completed - Hong Kong ... More >> Department of Medicine & Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong Hong Kong, Hong Kong Less <<
NCT02871882 Type 2 Diabetes Mellitus ... More >> Obese Overweight Less << Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT02072096 - Terminated(The trial was termi... More >>nated per protocol because of lack of feasibility.) Less << - -
NCT00855166 Type 2 Diabetes Mellitus Phase 3 Completed - Bulgaria ... More >> Research Site Blagoevgrad, Bulgaria Research Site Sofia, Bulgaria Czech Republic Research Site Beroun, Czech Republic Research Site Brno, Czech Republic Research Site Praha, Czech Republic Research Site Semily, Czech Republic Research Site Slany, Czech Republic Hungary Research Site Balatonfured, Hungary Research Site Budapest, Hungary Research Site Csongrad, Hungary Research Site Kecskemet, Hungary Research Site TAT, Hungary Poland Research Site Elblag, Poland Research Site Krakow, Poland Research Site Torun, Poland Sweden Research Site Goteborg, Sweden Research Site Jarfalla, Sweden Research Site Lund, Sweden Research Site Malmo, Sweden Research Site Stockholm, Sweden Research Site Uppsala, Sweden Less <<
NCT00855166 - Completed - -
NCT02365233 Type II Diabetes ... More >> Nonalcoholic Fatty Liver Less << Phase 4 Terminated(IRB withheld the da... More >>ta due to inadequate supporting documentation) Less << - United States, Texas ... More >> University of Texas Medical Branch -Galveston Galveston, Texas, United States, 77555 Less <<
NCT02365233 - Terminated(IRB withheld the da... More >>ta due to inadequate supporting documentation) Less << - -
NCT02072096 Diabetes Mellitus, Type 2 Phase 4 Terminated(The trial was termi... More >>nated per protocol because of lack of feasibility.) Less << - -
NCT01969357 Type 2 Diabetes Phase 2 Completed - China ... More >> Chinese PLA General Hospital Beijing, China Less <<
NCT02060383 Cushing's Disease ... More >> Acromegaly Less << Phase 4 Completed - -
NCT01349387 Type 2 Diabetes Not Applicable Completed - France ... More >> Centre Hospitalier Sud Francilien Corbeil Essonnes, France, 91106 Less <<
NCT01342939 - Completed - Denmark ... More >> Diabetes Research Division, Gentofte University Hospital, Niels Andersens vej 65, opgang 40, 2. Hellerup, Denmark, 2900 Less <<
NCT01767389 - Completed - -
NCT01198730 Diabetes Mellitus ... More >> Coronary Artery Disease Less << Not Applicable Recruiting December 2019 Taiwan ... More >> Taichung Veterans General Hospital Recruiting Taichung, Taiwan, 40705 Contact: Wayne H-H Sheu, MD, PHD       whhsheu@vghtc.gov.tw Less <<
NCT02493959 Healthy Early Phase 1 Completed - Denmark ... More >> Department of Endocrinology, Hvidovre Hospital Hvidovre, Denmark, DK-2650 Less <<
NCT02879409 Diabetes Mellitus Type 2 Not Applicable Recruiting August 2019 Qatar ... More >> Hamad Medical Corporation Recruiting Doha, Qatar, 3050 Contact: Ibrahim Janahi, MD    4439-2434 ext 00974    Imohd@hamad.qa    Principal Investigator: Ibrahim Janahi, MD          Sub-Investigator: Mashhood Siddique, MD          Sub-Investigator: Hamda Ali, MD Less <<
NCT01242228 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Chubu, Japan Hokkaido, Japan Kansai, Japan Kantou, Japan Kyushu, Japan Touhoku, Japan Less <<
NCT01999218 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02041234 Type II Diabetes in Subjects B... More >>MI 27 to 32 Less << Phase 4 Recruiting March 2020 Singapore ... More >> Khoo Teck Puat Hospital Recruiting Singapore, Singapore, 768828 Contact: Bernice Tan    +65 6602 3169    tan.bernice.lt@alexandrahealth.com.sg    Principal Investigator: Anton Cheng, MBBS          Sub-Investigator: Chee Fang Sum, MBBS          Sub-Investigator: Su Chi Lim, MBBS          Sub-Investigator: Tavintharan Subramaniam, MBBS          Sub-Investigator: Nitish Mishra, MBBS          Sub-Investigator: Ester Yeoh, MBBS          Sub-Investigator: Chun Hai Tan, MBBS          Sub-Investigator: Benjamin Chih Chiang Lam, MBBS          Sub-Investigator: Thazin Ma, MBBS          Sub-Investigator: Michael Wong, MBBS Less <<
NCT01999218 - Completed - -
NCT03115099 Diabetes Mellitus, Type 2 Phase 1 Completed - Singapore ... More >> For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician. Singapore, Singapore, 117597 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Singapore, Singapore Less <<
NCT02527993 Hypoglycemia ... More >>Obesity Surgery Less << Phase 4 Completed - -
NCT00676338 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00783549 Dyslipidaemias Phase 1 Completed - United States, Minnesota ... More >> GSK Investigational Site Minneapolis, Minnesota, United States, 55404 Less <<
NCT00871507 Diabetes Mellitus, Type 2 Phase 1 Completed - United States, Florida ... More >> Fort Myers, Florida, United States United States, Texas San Antonio, Texas, United States Less <<
NCT00676338 - Completed - -
NCT03180281 Type 2 Diabetes Mellitus Not Applicable Not yet recruiting January 1, 2020 China, Shaanxi ... More >> First Affiliated Hospital of Xi'an Jiao Tong University Not yet recruiting Xi'an, Shaanxi, China, 710061 Contact: Jing Sui, Doctor    0086-18991989230 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.91mL

0.38mL

0.19mL

9.55mL

1.91mL

0.96mL

19.11mL

3.82mL

1.91mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories